Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders

Journal of NeuroVirology

Volumn 18, Issue 4, 2012, Pages 313-322

  Soontornniyomkij, Virawudh ^a   Everall, Ian P ^b   Moore, David J ^a   Gouaux, Ben ^a   Tatro, Erick T ^a   Gospodarev, Vadim ^a   Masliah, Eliezer ^c   Yin, Nicole S ^d   Vinters, Harry V ^d   Achim, Cristian L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FKBP4; FKBP5; HIV dementia; Immunophilin; NR3C1

Indexed keywords

ANTIRETROVIRUS AGENT; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; GLUCOCORTICOID RECEPTOR; METHAMPHETAMINE; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METHAMPHETAMINE DEPENDENCE; MIDDLE FRONTAL GYRUS; NEUROANATOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SUBCORTEX; WHITE MATTER;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-RETROVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; MIDDLE AGED; PARAHIPPOCAMPAL GYRUS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; SUBSTANCE-RELATED DISORDERS; TACROLIMUS BINDING PROTEINS;

HEPATITIS C VIRUS;

EID: 84863704522     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0076-8     Document Type: Article

References (41)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799
2. Becker JT, Lopez OL, Dew MA, Aizenstein HJ (2004) Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18(Suppl 1):S11-S18
3. Binder EB (2009) The role of FKBP5, a co-chaperone of the gluco-corticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34(Suppl 1):S186-S195
4. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Pütz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Künzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Köhnlein O, Dabitz H, Brückl T, Müller N, Pfister H, Lieb R, Mueller JC, Lõhmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36:1319-1325
5. Bizon JL, Helm KA, Han JS, Chun HJ, Pucilowska J, Lund PK, Gallagher M (2001) Hypothalamic-pituitary-adrenal axis function and corticosterone receptor expression in behaviourally characterized young and aged Long-Evans rats. Eur J Neurosci 14:1739-1751
6. Caporello E, Nath A, Slevin J, Galey D, Hamilton G, Williams L, Steiner JP, Haughey NJ (2006) The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. J Neurochem 98:146-155
7. Chambraud B, Sardin E, Giustiniani J, Dounane O, Schumacher M, Goedert M, Baulieu EE (2010) A role for FKBP52 in Tau protein function. Proc Natl Acad Sci U S A 107:2658-2663
8. Chauhan A, Sharma U, Jagannathan NR, Reeta KH, Gupta YK (2011) Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res 225:603-609
9. Christeff N, Gherbi N, Mammes O, Dalle MT, Gharakhanian S, Lor-tholary O, Melchior JC, Nunez EA (1997) Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocri-nology 22(Suppl 1):S11-S18
10. Cioffi DL, Hubler TR, Scammell JG (2011) Organization and function of the FKBP52 and FKBP51 genes. Curr Opin Pharmacol 11:308-313
11. Datson NA, van der Perk J, de Kloet ER, Vreugdenhil E (2001) Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci 14:675-689
12. de Kloet ER, Joëls M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463-475
13. Goosens KA, Sapolsky RM (2007) Stress and glucocorticoid contributions to normal and pathological aging. In: Riddle DR (ed) Brain aging: models, methods, and mechanisms. CRC Press, New York, pp 305-314
14. Grad I, Picard D (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275:2-12
15. Hand GA, Phillips KD, Dudgeon WD (2006) Perceived stress in HIV-infected individuals: physiological and psychological correlates. AIDS Care 18:1011-1017
16. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J (1996) Psychiatric research interview for substance and mental disorders (PRISM): reliability for substance abusers. Am J Psychiatry 153:1195-1201
17. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocogni-tive disorders before and during the era of combination antiretro-viral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
18. Hellhammer DH, Wüst S, Kudielka BM (2009) Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 34:163-171
19. Hoeffer CA, Klann E (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33:67-75
20. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S, Horstmann S, Uhr M, Müller-Myhsok B, Holsboer F (2008) Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 28:389-398
21. Jääskeläinen T, Makkonen H, Palvimo JJ (2011) Steroid up-regulation of FKBP51 and its role in hormone signaling. Curr Opin Pharmacol 11:326-331
22. Jankord R, Herman JP (2008) Limbic regulation of hypothalamo-pituitary- adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 1148:64-73
23. Jayadev S, Garden GA (2009) Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders. J Neu-roimmune Pharmacol 4:175-189
24. Jinwal UK, Koren J, Borysov SI, Schmid AB, Abisambra JF, Blair LJ, Johnson AG, Jones JR, Shults CL, O'Leary JC, Jin Y, Buchner J, Cox MB, Dickey CA (2010) The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci 30:591-599
25. Koike K, Hashimoto K, Fukami G, Okamura N, Zhang L, Ohgake S, Koizumi H, Matsuzawa D, Kawamura N, Shimizu E, Iyo M (2005) The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Neurophar-macology 48:391-397
26. Kudielka BM, Kirschbaum C (2005) Sex differences in HPA axis responses to stress: a review. Biol Psychol 69:113-132
27. Lee RS, Tamashiro KL, Yang X, Purcell RH, Harvey A, Willour VL, Huo Y, Rongione M, Wand GS, Potash JB (2010) Chronic corti-costerone exposure increases expression and decreases deoxyri-bonucleic acid methylation of Fkbp5 in mice. Endocrinology 151:4332-4343
28. Levine AJ, Hinkin CH, Ando K, Santangelo G, Martinez M, Valdes-Sueiras M, Saxton EH, Mathisen G, Commins DL, Moe A, Farthing C, Singer EJ (2008) An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV + adults. J Clin Exp Neuropsychol 30:836-843
29. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT (2005) Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 30:225-242
30. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20:25-31
31. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER (2010) Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev 34:853-866
32. Reif S, Mugavero M, Raper J, Thielman N, Leserman J, Whetten K, Pence BW (2011) Highly stressed: stressful and traumatic experiences among individuals with HIV/AIDS in the Deep South. AIDS Care 23:152-162
33. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA et al (1988) The composite international diagnostic interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069-1077
34. Scharf SH, Liebl C, Binder EB, Schmidt MV, Müller MB (2011) Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One 6:e16883
35. Soontornniyomkij V, Risbrough VB, Young JW, Wallace CK, Soontornniyomkij B, Jeste DV, Achim CL (2010) Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brain. Age (Dordr) 32:309-322
36. Steiner JP, Galey D, Haughey NJ, Asch D, Nath A (2007) Neuro-protective and antiretroviral effects of the immunophilin ligand GPI 1046. J Neuroimmune Pharmacol 2:49-57
37. Tatro ET, Everall IP, Masliah E, Hult BJ, Lucero G, Chana G, Soontornniyomkij V, Achim CL (2009) Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder. J Neuroimmune Pharmacol 4:218-226
38. Touma C, Gassen NC, Herrmann L, Cheung-Flynn J, Büll DR, Ionescu IA, Heinzmann JM, Knapman A, Siebertz A, Depping AM, Hartmann J, Hausch F, Schmidt MV, Holsboer F, Ising M, Cox MB, Schmidt U, Rein T (2011) FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry 70:928-936
39. Wang L (2011) FKBP51 regulation of AKT/protein kinase B phosphory-lation. Curr Opin Pharmacol 11:360-364
40. Wei Q, Hebda-Bauer EK, Pletsch A, Luo J, Hoversten MT, Osetek AJ, Evans SJ, Watson SJ, Seasholtz AF, Akil H (2007) Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuroendocrine phenotype and mild cognitive dysfunction. J Neurosci 27:8836-8844
41. Wochnik GM, Rüegg J, Abel GA, Schmidt U, Holsboer F, Rein T (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280:4609-4616